Author Instructions: Difference between revisions - Compendium of Cancer Genome Aberrations

Line 9:

#Disease category overview pages (for example see [[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms]], which are summaries of a group of diseases with links to all other relevant content.

#Disease-specific pages (for example see any links on the AML page), which is for individual disease entities and much more detailed.

* For more details on how you use the site to be an author, please see an instructional video (see section below).

*For more details on how you use the site to be an author, please see an instructional video (see section below).

Please do use the provided tables if applicable.

*For the timeline, there’s some flexibility~~. We do not want~~ to ~~deter you with too aggressive~~ a ~~timeline but also would like~~ to ~~move forward as efficiently as possible. If~~ you ~~wish to contribute to this effort~~ (~~or mentor one of your trainees to do so)~~, ~~and once I know in which area~~, ~~I can connect you to an associate editor who would work with you to find a reasonable time goal and provide support during the process.~~

*For the timeline, there’s some flexibility and please work with your Associate Editor to set a target date.

*For any additional questions, please contact us at CCGA@cancergenomics.org add to the subject line the disease category you are interested in working on (i.e. MDS, ALL, etc)

==Video Tutorial==

@@ Line 9: / Line 9: @@
 #Disease category overview pages (for example see [[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms]], which are summaries of a group of diseases with links to all other relevant content.
 #Disease-specific pages (for example see any links on the AML page), which is for individual disease entities and much more detailed.
-* For more details on how you use the site to be an author, please see an instructional video (see section below).
+*For more details on how you use the site to be an author, please see an instructional video (see section below).
 Please do use the provided tables if applicable.
-*For the timeline, there’s some flexibility.  We do not want to deter you with too aggressive a timeline but also would like to move forward as efficiently as possible.  If you wish to contribute to this effort (or mentor one of your trainees to do so), and once I know in which area, I can connect you to an associate editor who would work with you to find a reasonable time goal and provide support during the process.
+*For the timeline, there’s some flexibility and please work with your Associate Editor to set a target date.
+*For any additional questions, please contact us at CCGA@cancergenomics.org add to the subject line the disease category you are interested in working on (i.e. MDS, ALL, etc)
 ==Video Tutorial==